thyssenkrupp nucera AG & Co. KGaA

XTRA:NCH2 Stock Report

Market Cap: €1.1b

thyssenkrupp nucera KGaA Future Growth

Future criteria checks 3/6

thyssenkrupp nucera KGaA is forecast to grow earnings and revenue by 82.5% and 2% per annum respectively. EPS is expected to grow by 81.1% per annum. Return on equity is forecast to be 3.3% in 3 years.

Key information

82.5%

Earnings growth rate

81.14%

EPS growth rate

Construction earnings growth11.0%
Revenue growth rate2.0%
Future return on equity3.26%
Analyst coverage

Good

Last updated01 Jun 2026

Recent future growth updates

Recent updates

Narrative Update May 23

NCH2: Large Hydrogen Contracts Will Support Future Earnings Recovery Potential

Analysts have maintained their price target for thyssenkrupp nucera KGaA at €15.00. Updated assumptions indicate higher expected revenue growth and profit margins, partly offset by a slightly higher discount rate and a marginally lower future P/E.
Narrative Update May 03

NCH2: Long Dated Hydrogen Orders Will Support Future Margin Upside

Analysts have trimmed their price target for thyssenkrupp nucera KGaA slightly, from €10.89 to €10.74, reflecting updated assumptions for slower revenue growth, a higher discount rate and a lower future P/E multiple, partly offset by a stronger profit margin outlook. What's in the News The company hosted an Analyst/Investor Day, providing the market with a detailed update on the business and project pipeline (Analyst/Investor Day).
Narrative Update Apr 18

NCH2: New Hydrogen Contracts And Guidance Reset Will Support Earnings Recovery

Analysts kept their €15.00 price target for thyssenkrupp nucera KGaA unchanged, pointing to only minor tweaks to assumptions such as a slightly higher discount rate, a small adjustment in revenue growth and profit margin expectations, and a marginally lower future P/E multiple. What's in the News thyssenkrupp nucera plans an Analyst/Investor Day.
Narrative Update Apr 04

NCH2: Future Hydrogen Project Pipeline Will Drive Order Backlog Upside

Analysts have adjusted the price target for thyssenkrupp nucera KGaA from €10.52 to €10.89, citing updated assumptions around discount rates, revenue trends, profit margins and future P/E expectations. What's in the News thyssenkrupp nucera held an Analyst and Investor Day, giving the market more detail on its business outlook and project pipeline (company event).
Narrative Update Mar 20

NCH2: Contracted Pipeline And 2025 Guidance Will Support Earnings Recovery

Analysts have maintained their €15.00 price target for thyssenkrupp nucera KGaA, with only very small adjustments to their models for discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News thyssenkrupp nucera AG & Co. KGaA held an Analyst/Investor Day, providing a platform for management to update the market on the business and its project pipeline (Key Developments).
Narrative Update Mar 06

NCH2: Future Large Middle East Orders Will Support Earnings Recovery

Analysts now maintain a €15.00 price target for thyssenkrupp nucera KGaA, with the unchanged figure reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions that broadly offset one another. What's in the News The company reiterated its earnings guidance for 2025/26, expecting order intake between €350 million and €900 million, group sales between €500 million and €600 million, and consolidated EBIT in a range from a loss of €30 million to break even (Corporate Guidance).
Narrative Update Feb 19

NCH2: Future Chlor Alkali Orders Will Support Earnings Recovery

Analysts have trimmed their price target on thyssenkrupp nucera KGaA from €16.00 to €15.00, reflecting updated assumptions for slightly lower revenue growth, a higher discount rate, a marginally stronger profit margin, and a higher future P/E multiple. What's in the News The company reiterates earnings guidance for 2025/26, expecting group order intake between €350 million and €900 million and group sales between €500 million and €600 million, mainly supported by major new build projects and chlor-alkali service demand (company guidance).
Narrative Update Feb 05

NCH2: Weak Medium Term Sales Outlook Will Constrain Margin Recovery

Analysts have trimmed their price target for thyssenkrupp nucera KGaA slightly, reflecting updated assumptions for a modest revenue decline alongside a small improvement in profit margin and P/E expectations. What's in the News Thyssenkrupp nucera AG & Co. KGaA has been removed from the Germany SDAX (Total Return) Index, changing its position among smaller listed German companies (Index Constituent Drops).
Narrative Update Jan 21

NCH2: Softer Orders And Modest Margin Gains Will Shape Fairly Valued Outlook

Analysts have nudged their price target for thyssenkrupp nucera KGaA higher from €7.80 to €8.20, citing updated assumptions that factor in a slightly higher discount rate, softer revenue growth expectations, a higher projected profit margin at 5.65% and a marginally richer future P/E of about 38.6x. What's in the News thyssenkrupp nucera AG & Co. KGaA has been removed from the Germany SDAX (Total Return) Index, which may affect how some index-tracking funds hold or trade the stock (Key Developments).
Analysis Article Jan 15

There's Reason For Concern Over thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Price

It's not a stretch to say that thyssenkrupp nucera AG & Co. KGaA's ( ETR:NCH2 ) price-to-sales (or "P/S") ratio of 1.4x...
Narrative Update Jan 06

NCH2: Long Term Hydrogen Order Backlog Will Drive Future Upside

Analysts have trimmed their price target for thyssenkrupp nucera KGaA slightly. The fair value estimate has moved from €10.75 to €10.52, reflecting updated assumptions for lower revenue growth, a higher discount rate, improved profit margins and a reduced future P/E multiple.
Narrative Update Dec 20

NCH2: Weaker Green Hydrogen Orders Will Pressure Profits And Share Price

Analysts have trimmed their price target on thyssenkrupp nucera KGaA by roughly 10 percent, citing slightly weaker revenue growth expectations and a higher discount rate, which are partly offset by improved profit margin and a lower future price to earnings multiple. What's in the News Company issued new guidance for fiscal 2025/26, forecasting a sharp drop in group sales to between €500 million and €600 million from €845 million in 2024/25, with EBIT expected between €-30 million and €0 million.
Narrative Update Dec 05

NCH2: Upcoming Electrolyzer Efficiency And Service Expansion Will Drive Future Upside

Analysts have trimmed their price target on thyssenkrupp nucera KGaA by approximately €0.86 to around €10.75. This reflects more cautious assumptions on revenue growth, profit margins, and the appropriate discount rate, despite higher long term valuation multiples.
Analysis Article Nov 28

Analysts Just Slashed Their thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) EPS Numbers

Market forces rained on the parade of thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ) shareholders today, when the...
Analysis Article Nov 27

Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 25%?

Key Insights The projected fair value for thyssenkrupp nucera KGaA is €9.92 based on 2 Stage Free Cash Flow to Equity...
Analysis Article Nov 03

Is Now The Time To Look At Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ), is not the largest company out there, but it saw significant share...
Analysis Article Oct 07

thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) 26% Share Price Surge Not Quite Adding Up

thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ) shares have had a really impressive month, gaining 26% after a shaky...
Narrative Update Sep 18

Global Decarbonization Policies Will Fuel Green Hydrogen Momentum

The reduction in thyssenkrupp nucera KGaA’s consensus revenue growth outlook has outweighed the minor improvement in net profit margin, resulting in a lowered analyst price target from €11.93 to €11.61. What's in the News Progressive Green Solutions selected thyssenkrupp nucera as preferred supplier of 1.4 GW electrolyzers for its Western Australia Mid-West Green Iron project, marking a significant green hydrogen technology deployment.
Analysis Article Aug 18

thyssenkrupp nucera KGaA (ETR:NCH2) Is Posting Healthy Earnings, But It Is Not All Good News

XTRA:NCH2 1 Year Share Price vs Fair Value Explore thyssenkrupp nucera KGaA's Fair Values from the Community and select...
Analysis Article Aug 16

thyssenkrupp nucera AG & Co. KGaA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

XTRA:NCH2 1 Year Share Price vs Fair Value Explore thyssenkrupp nucera KGaA's Fair Values from the Community and select...
Analysis Article Jul 30

Is It Too Late To Consider Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

While thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ) might not have the largest market cap around , it received a lot...
Analysis Article Jul 02

Weekly Picks: 💸 SUN's Insurance Dividends, NCH2's Hydrogen Exposure, and TSLA's Robotic Inflection Point

Why Suncorp’s insurance-only pivot gives it room to grow revenues, why Thyssenkrupp Nucera can leverage its unique position for green hydrogen adoption, and why Tesla is reaching an AI and robotics inflection point
Analysis Article Jun 26

Should You Be Adding thyssenkrupp nucera KGaA (ETR:NCH2) To Your Watchlist Today?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
New Narrative Apr 30

Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth

EBIT-margin trajectory:Historical: 2.3 % → 3.6 % (FY 22/23) ​, down to – 2 % (FY 23/24) ​, back to 3 % in Q1 24/25 ​Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30
User avatar
New Narrative Jan 27

Upcoming NEOM Project And SOEC Technology Will Strengthen Position In Green Hydrogen Market

Strategic partnerships and R&D investments in SOEC technology position thyssenkrupp nucera for growth and improved margins in the hydrogen industry.
Analysis Article Dec 20

thyssenkrupp nucera AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders of thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ) will be pleased this week, given that the stock price is...
Analysis Article Dec 10

thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Popularity With Investors Is Clear

thyssenkrupp nucera AG & Co. KGaA's ( ETR:NCH2 ) price-to-sales (or "P/S") ratio of 1.4x may not look like an appealing...
Analysis Article Aug 16

Earnings Miss: thyssenkrupp nucera AG & Co. KGaA Missed EPS By 15% And Analysts Are Revising Their Forecasts

Shareholders of thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ) will be pleased this week, given that the stock price is...
Analysis Article May 08

Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 41%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, thyssenkrupp nucera KGaA fair value estimate is €21.39...
Analysis Article Jan 07

Is thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) Trading At A 39% Discount?

Key Insights thyssenkrupp nucera KGaA's estimated fair value is €25.96 based on 2 Stage Free Cash Flow to Equity...

Earnings and Revenue Growth Forecasts

XTRA:NCH2 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20287343619508
9/30/202760917-1259
9/30/2026515-37-20510
12/31/2025730-7-2316N/A
9/30/202584551150N/A
6/30/202591616-719N/A
3/31/202596924-45-22N/A
12/31/202491818-55-37N/A
9/30/202486211-75-62N/A
6/30/20247775-71-64N/A
3/31/20247275-64-60N/A
12/31/202371218-31-26N/A
9/30/202366124-17-13N/A
6/30/202360217810N/A
3/31/2023513147576N/A
12/31/2022450128284N/A
9/30/202238368687N/A
9/30/2021319213637N/A
9/30/20202542224N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NCH2 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: NCH2 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NCH2 is expected to become profitable in the next 3 years.

Revenue vs Market: NCH2's revenue (2% per year) is forecast to grow slower than the German market (6.7% per year).

High Growth Revenue: NCH2's revenue (2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NCH2's Return on Equity is forecast to be low in 3 years time (3.3%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 23:22
End of Day Share Price 2026/06/03 00:00
Earnings2025/12/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

thyssenkrupp nucera AG & Co. KGaA is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Virginia Sanz de Madrid GrossBanco Santander
James CarmichaelBerenberg
Alexander JonesBofA Global Research